Detalhe da pesquisa
1.
Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing.
Nat Med
; 12(7): 852-5, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16799556
2.
The tumor suppressor Cdc73 functionally associates with CPSF and CstF 3' mRNA processing factors.
Proc Natl Acad Sci U S A
; 106(3): 755-60, 2009 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-19136632
3.
Non-small-cell lung cancer and Ba/F3 transformed cells harboring the ERBB2 G776insV_G/C mutation are sensitive to the dual-specific epidermal growth factor receptor and ERBB2 inhibitor HKI-272.
Cancer Res
; 66(13): 6487-91, 2006 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16818618
4.
Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain.
PLoS Med
; 3(12): e485, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17177598
5.
Allele-dependent variation in the relative cellular potency of distinct EGFR inhibitors.
Cancer Biol Ther
; 6(5): 661-7, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17495523
6.
Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors.
Proc Natl Acad Sci U S A
; 103(20): 7817-22, 2006 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-16672372